A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumors

Authors:

Abstract
No abstract available
Funding Information
  • Dana-Farber Cancer Institute
  • Novartis Pharmaceuticals Corporation
  • National Institutes of Health (R01CA238039)

This publication has 89 references indexed in Scilit: